IL164904A0 - Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one - Google Patents

Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one

Info

Publication number
IL164904A0
IL164904A0 IL16490404A IL16490404A IL164904A0 IL 164904 A0 IL164904 A0 IL 164904A0 IL 16490404 A IL16490404 A IL 16490404A IL 16490404 A IL16490404 A IL 16490404A IL 164904 A0 IL164904 A0 IL 164904A0
Authority
IL
Israel
Prior art keywords
methyl
preparing
methylü
carbazol
imidazol
Prior art date
Application number
IL16490404A
Other languages
English (en)
Original Assignee
Biogal Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Pharmaceutical Co Ltd filed Critical Biogal Pharmaceutical Co Ltd
Publication of IL164904A0 publication Critical patent/IL164904A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL16490404A 2002-04-29 2004-10-28 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one IL164904A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37632302P 2002-04-29 2002-04-29
PCT/US2003/013221 WO2003093281A1 (en) 2002-04-29 2003-04-29 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one

Publications (1)

Publication Number Publication Date
IL164904A0 true IL164904A0 (en) 2005-12-18

Family

ID=29401332

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16490404A IL164904A0 (en) 2002-04-29 2004-10-28 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one

Country Status (19)

Country Link
US (2) US7098345B2 (xx)
EP (1) EP1499623B1 (xx)
JP (1) JP2005529142A (xx)
KR (1) KR20040104654A (xx)
CN (1) CN1665823A (xx)
AT (1) ATE364611T1 (xx)
AU (1) AU2003223764A1 (xx)
CA (1) CA2483566A1 (xx)
DE (1) DE60314400T2 (xx)
DK (1) DK1499623T3 (xx)
ES (1) ES2288606T3 (xx)
HR (1) HRP20041070A2 (xx)
IL (1) IL164904A0 (xx)
MX (1) MXPA04010846A (xx)
NO (1) NO20045192L (xx)
PL (1) PL373191A1 (xx)
PT (1) PT1499623E (xx)
WO (1) WO2003093281A1 (xx)
ZA (1) ZA200408934B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU32003A (sh) * 2000-10-30 2006-05-25 Teva Pharmaceutical Industries Ltd. Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje
CA2483532A1 (en) * 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
US7547791B2 (en) * 2004-10-26 2009-06-16 Ipca Laboratories Ltd. One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561244B1 (fr) 1984-01-25 1988-03-04 Glaxo Group Ltd Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0405617A3 (en) 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518741D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US4859662A (en) 1986-11-28 1989-08-22 Glaxo Group Limited Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances
GB8630071D0 (en) 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5344658A (en) 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
CA2112487C (en) 1991-06-26 2003-04-15 James W. Young Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2106642C (en) 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
YU32003A (sh) 2000-10-30 2006-05-25 Teva Pharmaceutical Industries Ltd. Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje
EP1207160A1 (en) 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
CA2433720A1 (en) 2001-01-11 2002-07-18 Teva Pharmaceutical Industries Ltd. An improved process for preparing pure ondansetron hydrochloride dihydrate
AU2002251329A1 (en) 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
CA2483532A1 (en) 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them

Also Published As

Publication number Publication date
ZA200408934B (en) 2006-07-26
MXPA04010846A (es) 2005-01-25
CN1665823A (zh) 2005-09-07
NO20045192L (no) 2005-01-28
ATE364611T1 (de) 2007-07-15
WO2003093281A1 (en) 2003-11-13
KR20040104654A (ko) 2004-12-10
EP1499623B1 (en) 2007-06-13
EP1499623A1 (en) 2005-01-26
US20050020655A1 (en) 2005-01-27
HRP20041070A2 (en) 2005-02-28
CA2483566A1 (en) 2003-11-13
AU2003223764A1 (en) 2003-11-17
DK1499623T3 (da) 2007-10-08
PT1499623E (pt) 2007-08-10
DE60314400D1 (de) 2007-07-26
US20060252942A1 (en) 2006-11-09
DE60314400T2 (de) 2008-02-07
ES2288606T3 (es) 2008-01-16
PL373191A1 (en) 2005-08-22
JP2005529142A (ja) 2005-09-29
US7098345B2 (en) 2006-08-29

Similar Documents

Publication Publication Date Title
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
EP1386922A3 (en) Synthesis of epothilones, intermediates thereof, analogues and uses thereof
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
PL371582A1 (en) Difluoromethyl thiazolyl carboxanilides
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03004187A (es) Produccion de acido 6-aminocaproico.
TW200504011A (en) Process and intermediates for the preparation of pyrrolidine carboxylic acids
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
SI1509517T1 (sl) Nova sinteza irbesartana
WO2006052768A3 (en) Process for preparing quinoline compounds and products obtained therefrom
SG144736A1 (en) Synthesis of temozolomide and analogs
MX2007004591A (es) Proceso para la preparacion de compuestos organicos.
WO2002092564A3 (en) Synthesis of cyclopentadiene derivatives
IL164904A0 (en) Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
Verrier et al. Highly diastereoselective addition of alkoxyethynyl aluminium reagents to N-tert-butylsulfinyl aldimines
SG143062A1 (en) Synthesis of temozolomide and analogs
WO2008021491A3 (en) Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
PL1877370T3 (pl) Sposób wytwarzania pochodnych hydrazonu
WO2021076835A8 (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
IL156141A0 (en) A process for the preparation of taxan derivatives
GB9909229D0 (en) Enantiomers of mercapto lactones and processes for their synthesis
MX2009009232A (es) Nuevo procedimiento de preparacion de 3-metil-4-fenilsoxazolo [3,4-d]piridazin-7(6h)-ona.
IL158933A0 (en) Method for the production of biperiden ii